News
Phase 2 trial of EDG-7500 demonstrated rapid and clinically meaningful reductions in LVOT gradients in participants with obstructive HCM – – Four-week treatment with EDG-7500 demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback